ADAR1 Capital Management »

Cellectar Biosciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.2M 1.0M 2.14
2024-06-30 $1.7M 682k 2.50
2024-03-31 $2.6M 643k 3.98
2023-12-31 $3.8M 1.4M 2.77

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Cellectar Biosciences

Rosalind Advisors
AIGH Capital Management
Nantahala Capital Management
Vanguard Group
ADAR1 Capital Management
Geode Capital Management
BlackRock
Altium Capital Management
Bank of America Corporation
Barclays
State Street Corporation
Citadel Advisors
Northern Trust
XTX Topco
Susquehanna International

View all funds holding Cellectar Biosciences